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• A network-based model may be able to describe apathy in cerebrovascular disease. 
• Focal network damage, such as in stroke, could lead to network failure and apathy. 
• Changes to remote regions or network disconnection can lead to apathy over time. 
• Specific subnetworks may underlie motivation-related cognitive functioning. 
• Understanding the network basis of apathy could lead to targeted treatments. 
 
Abstract 
Apathy is a reduction in motivated goal-directed behavior (GDB) that is prevalent in 
cerebrovascular disease, providing an important opportunity to study the mechanistic 
underpinnings of motivation in humans. Focal lesions, such as those seen in stroke, have been 
crucial in developing models of brain regions underlying motivated behavior, while studies of 
cerebral small vessel disease (SVD) have helped define the connections between brain regions 
supporting such behavior. However, current lesion-based models cannot fully explain the 
neurobiology of apathy in stroke and SVD. To address this, we propose a network-based model 










current evidence suggests that cerebrovascular disease-related pathology can lead to network 
changes outside of initially damaged territories, which may propagate to regions that share 
structural or functional connections. The presentation and longitudinal trajectory of apathy in 
stroke and SVD may be the result of these network changes. Distinct subnetworks might 
support cognitive components of GDB, the disruption of which results in specific symptoms of 
apathy. This network-based model of apathy may open new approaches for investigating its 
underlying neurobiology, and presents novel opportunities for its diagnosis and treatment. 
 
Abbreviations: SVD = small vessel disease; GDB = goal-directed behavior; WMH = white matter 
hyperintensities; PFC = prefrontal cortex; ACC = anterior cingulate cortex; OFC = orbitofrontal 
cortex; SMA = supplementary motor area; NAA = N-acetylaspartate; rCBF = regional cerebral 
blood flow; DTI = diffusion tensor imaging; FA = fractional anisotropy; rTMS = repetitive 
transcranial magnetic stimulation; CADASIL = Cerebral Autosomal Dominant Arteriopathy with 
Subcortical Infarcts and Leukoencephalopathy; CRP = C-reactive protein; TMT-B = Trail Making 
Test part B; BMI = body mass index. 
 




Apathy is a behavioral syndrome that is characterized by a loss of motivation (Marin, 











Ferro, and Costa, 2013; van Dalen et al., 2013) and is a prominent symptom in sporadic and 
genetic cerebral small vessel disease (SVD) (Reyes et al., 2009; Tay et al., 2019). The prevalence 
of apathy may be higher in vascular dementia - a condition that results from the impact of 
cerebrovascular disease on the brain - when compared to Alzheimer's disease (Bandyopadhyay 
et al., 2014; Fuh et al., 2005; Hargrave et al., 2000). Furthermore, apathy in itself is a risk factor 
for incident stroke, myocardial infarction, dementia, and mortality (Eurelings et al., 2018; van 
Dalen et al., 2018). 
Recent research on the fundamental neuroanatomical and neurocognitive mechanisms 
underlying apathy has broadened our understanding of apathy in cerebrovascular disease and 
across neurological disorders. Despite this, theoretical work has primarily focused on linking 
neurodegenerative pathology to apathy, such as in Alzheimer's disease or Parkinson's disease 
(e.g., Lanctôt et al., 2017; Pagonabarraga et al., 2015). This has left the mechanisms underlying 
apathy in cerebrovascular disease comparably under-explored. Given the high prevalence of 
comorbid vascular pathology in neurodegenerative conditions (Iadecola, 2010), insights into 
apathy in cerebrovascular disease might also prove useful in elucidating brain mechanisms 
underlying motivation in healthy individuals and apathy across a range of diseases. 
We begin by briefly introducing the concept of apathy, as well as challenges in 
understanding it through current frameworks (Section 2). We then propose a network-based 
theory to explain the pathogenesis of apathy in stroke and SVD (Section 3). The cognitive 
mechanisms that may link network damage to apathy are then discussed (Section 4). Next, we 











important methodological consideration (Section 5). Future areas for research are then 
reviewed (Section 6). 
2. Apathy: concept and challenges 
Apathy is defined as a loss of motivation that manifests as a reduction in goal-directed 
behavior (GDB) (Levy and Dubois, 2006; Marin, 1991). This is defined in relation to a patient's 
previous level of functioning, in order to account for the interindividual, environmental, and 
sociocultural factors that may influence normative functioning. In addition to reductions in 
GDB, it is also recognized that there may be other aspects to apathy including emotional 
blunting, lack of motivation to interact socially and reduced intellectual curiosity (Robert et al., 
2018). Other terms used to describe different but related manifestations of apathy in the 
literature include abulia, athymhormia, and auto-activation deficit (Levy and Dubois, 2006). 
Importantly, apathy can be dissociated from depression in cerebrovascular diseases and 
in other neurological conditions more generally (Oguru et al., 2010; Starkstein et al., 2005; Tay 
et al., 2019; Withall et al., 2011). A substantial body of evidence suggests that the two 
constructs, when examined as broad syndromes, are dissociable in terms of neurobiology 
(Douven, Köhler, Rodriguez, et al., 2017), cognition (Fishman et al., 2018a, 2018b; Lohner et al., 
2017), longitudinal trajectories (Caeiro, Ferro, Pinho e Melo, et al., 2013; Withall et al., 2011), 
and impact on functional outcomes (Hama et al., 2007; Hollocks et al., 2015; Mayo et al., 2009). 
Comorbidity estimates range between 3.8 - 41.9% (Matsuzaki et al., 2015; Withall et al., 2011), 











Some behavioral manifestations of apathy may overlap with those seen in depressive 
disorders. For instance, diminished pleasure and energy, which are symptoms seen in major 
depressive disorder (American Psychiatric Association, 2013), may resemble symptoms of 
apathy. This overlap is likely due to the fact that the syndromes of apathy and depression, as 
currently defined, are collections of symptoms. As a result, overlapping symptoms such as 
diminished pleasure may share a common neurobiological basis (Cuthbert and Insel, 2013; 
Husain and Roiser, 2018), although little research has explicitly tested this. Dissociating 
between apathy and depression, while a clinically important question, is beyond the scope of 
this review, which will focus on the mechanisms leading cerebrovascular disease to apathy. 
Reviews on the conceptual and empirical differences between apathy and depression can be 
found elsewhere (Douven, Köhler, Rodriguez, et al., 2017; Marin, 1991; Starkstein and Manes, 
2000). 
Several frameworks have attempted to explain apathy in terms of specific 
neurobiological deficits. The most influential of these is by Levy and Dubois (2006), who 
proposed, from a theoretical perspective, that the symptoms of apathy can be conceptualized 
as 'emotional-affective', 'cognitive', and/or 'auto-activation' deficits. It has been proposed that 
these symptoms arise spontaneously as a consequence of focal damage or disruption to 
territories within the basal ganglia and prefrontal cortex (PFC), which may constitute a core 
subcortical-cortical circuit underlying GDB. This framework has guided much apathy research 
over the past decade, and has been incorporated into proposed diagnostic criteria and several 











Unfortunately, empirical evidence that supports the three separate dissociable 
constructs proposed by Levy and Dubois (2006) remains scarce. This is especially true regarding 
apathy in cerebrovascular disease. If apathy is the product of lesions to specific regions of the 
basal ganglia or PFC, then one would expect a clear relationship between stroke location and 
the presentation of apathy symptoms. This, however, has proven not to be the case, as lesions 
are distributed heterogeneously in patients with apathy (Sagnier et al., 2019; Tang et al., 2013; 
Yang, X.-y. Shang, et al., 2015). Furthermore, meta-analytic evidence suggests that there is no 
clear relationship between lesion location and the development of post-stroke apathy (Douven, 
Köhler, Rodriguez, et al., 2017; van Dalen et al., 2013), although this may be partially explained 
by whole-brain lesion-symptom mapping studies being underpowered to detect such effects. 
Other findings also appear anomalous, or difficult to explain, when viewed through this 
framework. For instance, some patients who are apathy-free during the acute phase of stroke 
develop it one year later, while other patients with apathy in the acute phase recover after one 
year (Caeiro, Ferro, Pinho e Melo, et al., 2013; Withall et al., 2011). If apathy develops 
spontaneously after a focal basal ganglia or PFC lesion, then why would apathy present up to a 
year later? Conversely, what mechanisms lead to some patients with apathy recovering normal 
function? These questions make it clear that a classical lesion-deficit model of apathy is unable 
to explain the full clinical phenotype of the syndrome in cerebrovascular disease. 
3. A network model linking cerebrovascular pathology and apathy 
We propose that apathy might potentially be better understood as a syndrome caused 











the tenets of graph theory and network analysis (Bullmore and Sporns, 2009), which have 
recently been able to explain and synthesize an impressive array of neuroscientific data (e.g., 
Schindlbeck and Eidelberg, 2018). This section will begin with a brief overview of network 
neuroscience (Section 3.1), followed by a proposal of the network mechanisms underlying 
apathy (Section 3.2). Evidence to support the hypothesis that apathy is a syndrome of network 
disruption is then reviewed in stroke (Section 3.3) and SVD (Section 3.4). A discussion of the 
anatomical subnetworks and cognitive mechanisms underlying apathy can be found in Section 
4. 
3.1. Fundamentals of network neuroscience 
The study of brain networks has been made increasingly more tractable with the 
application of graph theory. A graph has two fundamental elements: nodes and their 
connecting edges. In the context of macroscopic whole-brain networks, nodes are typically 
defined using a parcellation that divides the brain using predefined criteria, such as on the basis 
of sulci and gyri (e.g., Desikan et al., 2006) or cyto- and myelo-architecture (e.g., Eickhoff et al., 
2005), while edges are defined based on the context of the study. For example, studies on 
structural connectivity can define an edge as the probability that two regions are connected by 
a white matter tract. In studies of functional connectivity, edges can be defined as the 
correlation between the time series of two regions (Bullmore and Sporns, 2009). 
This graph-based representation of the brain can then be quantitatively analyzed to 
make inferences based on network topology. Two fundamental network measures are degree 










other nodes (Figure 1A). High-degree nodes are known as network hubs, which are core 
elements of large-scale brain networks (van den Heuvel and Sporns, 2013). Due to a large 
number of connections with other nodes, hubs participate in a diverse set of cognitive functions 
(Bassett et al., 2009), albeit at an increased metabolic cost (Collin et al., 2013). Hubs can be 
contrasted with low-degree peripheral nodes, which tend to show more local and specialized 
patterns of connectivity. A more comprehensive discussion of hubs can be found elsewhere 
(van den Heuvel and Sporns, 2013). 
FIGURE 1 AROUND HERE 
Another important network measure is efficiency, which measures the ease of 
information transfer in a network (Latora and Marchiori, 2001). The shortest path length 
between two nodes minimizes the number of edges traversed between the two (Figure 1B). 
The average inverse shortest path length between all nodes in a network is its global efficiency, 
and is a measure of overall integration in a network. The local efficiency of a node is the global 
efficiency of a subgraph composed of all first-degree neighbors of that node. The average local 
efficiency across all nodes is a measure of segregation and specialization. More rigorous 
mathematical definitions of these concepts can be found elsewhere (Latora and Marchiori, 
2001; Watts and Strogatz, 1998). Global and local efficiency are susceptible to neuropathology 
(Rubinov and Sporns, 2010). 
The effects of brain pathology can be described using network models (Fornito et al., 
2015). Direct damage to network hubs, such as through focal ischemia or hemorrhage, could 
lead to apathy. However, cerebrovascular disease may also lead to remote changes that result 











discussed: diaschisis and transneuronal degeneration. Diaschisis refers to a functional deficit in 
a region that is connected to a focally damaged area (Figure 1C), which is mediated by a 
reduction or interruption in the connectivity between the two regions (Carrera and Tononi, 
2014). This can be operationalized as reduced glucose metabolism or regional cerebral blood 
flow (rCBF) in the area of diaschisis, under the assumption that neurovascular coupling 
(functional hyperemia) is preserved in this region (Baron et al., 1984). Although these functional 
deficits were once thought to be temporary and reversible, this notion has been challenged by 
recent evidence suggesting that morphological changes may occur in remote regions directly 
connected to an infarct (Duering et al., 2015). These changes are also seen in young stroke 
patients (Schaapsmeerders et al., 2016), suggesting that they are related to stroke and not a 
different neurodegenerative pathology. Secondary morphological damage is consistent with 
transneuronal degeneration (Figure 1D), a process by which damage to distant nodes 
propagates through structural or functional connections (Fornito et al., 2015). 
It is important to stress that the interpretation of these measures, as well as the 
network pathologies described, should be carefully considered in the context of how nodes 
were defined. For instance, consider two network studies: one using structural magnetic 
resonance imaging (MRI) to define nodes on the basis of sulci and gyri, another using 
microelectrode arrays to define nodes on the basis of implanted electrodes. In the former case, 
each node represents the large-scale organization and dynamics of several millions of neurons, 
while in the latter, each node can capture the function of approximately three neighboring 
neurons (Schroeter et al., 2015). It is clear that inferences made on one cannot and should not 











macroscopic networks can be derived using data-driven or random parcellations at the group or 
participant level (de Reus and van den Heuvel, 2013). 
The following sections in this review consider the network mechanisms underlying 
apathy in the context of large-scale macroscopic networks. These are described at resolutions 
available for conventional MRI or computerized tomography out of necessity, given that the 
overwhelming majority of apathy research is conducted in vivo on humans using these 
techniques. 
3.2. Candidate network mechanisms underlying apathy 
The network measures that we have previously described, such as nodal degree and 
efficiency, allow us to reconceptualize the neurobiological basis of apathy. We propose that the 
hub nodes of GDB-related networks correspond to the structures found to be associated with 
apathy across neurological diseases. These include the anterior cingulate cortex (ACC), medial 
orbitofrontal cortex (OFC), ventral striatum, medial thalamus, and ventral tegmental area (Kos 
et al., 2016; Le Heron, Apps, et al., 2018). These structures play important roles in the cognitive 
processes that guide effort-based decision-making in healthy individuals (Le Heron, Apps, et al., 
2018), so it is reasonable to suppose that they form a foundation for motivation-related brain 
networks in humans. Damage to these putative network hubs - such as through focal ischemic 
or hemorrhagic stroke - can lead to immediate failure of GDB-related cognitive functions, which 
would then manifest as apathy. This view effectively subsumes the classical lesion-based view 











In contrast to hub node damage, peripheral node damage may result in diaschisis or 
transneuronal degeneration. Based on the connectivity profile of the damaged node, these 
pathologies can lead to apathy by spreading to a remote hub node, or through progressive 
damage over time to GDB-related subnetworks. The former case can be illustrated by a 
hypothetical patient with a focal supplementary motor area (SMA) infarct. SMA shares direct 
white matter connections with the ACC, a hub node, in the form of branching U-fibers from the 
corticospinal tract (Nachev et al., 2008; Vergani et al., 2014). These structural connections form 
the basis of functional interactions between these areas. One relevant GDB-related function is 
the formation of intentions to move, which is characterized by ramping activity of neural 
populations in SMA, followed by corresponding increases in neural activity in ACC (Fried et al., 
2011). This may reflect the formation of motor execution plans or an attempt for ACC to 
integrate the information to the rest of the network. In either case, SMA damage may lead to 
reduced functioning in connected ACC neurons, which have been deprived of a direct input 
(diaschisis). Over time, poor axonal nutrient transport and mitochondrial dysfunction lead to 
the anterograde degeneration of axons (Coleman, 2005) in cingulate motor fibers and then 
within the ACC itself (transneuronal degeneration). In both cases, according to the model we 
propose here, apathy is the result. 
The parietal-premotor network can be used as an example to consider how progressive 
damage to subnetworks might lead to apathy, as this has been implicated in a recent network 
study of the condition (Tay et al., 2019). This network consists primarily of the premotor and 
posterior parietal cortices, which form a relatively closed loop underlying movement intention 











or disconnection of the structures within this loop, while not directly leading to apathy, may 
impair the synchronous timing of neural signals necessary for movement. This decreased 
network efficiency makes complex movements more difficult to execute, leading to perceived 
task-related effort costs appearing greater (Zénon et al., 2015), as the network needs to work 
harder (i.e., expend more energy) to achieve normal levels of functioning (Ginsberg et al., 
1989). The result is postulated to lead to an overall decrease of GDB which might not be severe 
enough to meet criteria for an apathetic state. Over time, diaschisis and transneuronal 
degeneration occur within this network, leading to greater efficiency deficits that manifest as 
increasing apathy. The function of these structures and circuits has been simplified here for the 
purposes of illustrating how damage to non-hub nodes may lead to apathy. A more detailed 
discussion of the functional anatomy of these networks, and how damage to them may lead to 
apathy, can be found in Section 4. 
The subsequent subsections will review evidence that suggests that apathy can be 
modeled as a network pathology in stroke (Section 3.3) and SVD (Section 3.4). Prior to this, 
however, we clarify the neuroanatomical terminology used in these sections, as well as the 
studies included in the scope of the discussion. Although GDB may have a firm basis in specific 
brain regions and connections, very few studies have examined apathy using this level of 
granularity. This may be a consequence of small sample sizes in most studies, which limits the 
number of patients with isolated infarcts in each area. Our description of research on a per-
study basis will therefore reflect the terminology used by the authors as closely as possible, 
since extrapolation to more specific structures is not possible. Additionally, any research that 











divisions (e.g., left/right hemisphere, anterior/posterior, etc.) will not be discussed, as these are 
too nonspecific to aid a mechanistic understanding of apathy. 
3.3. Apathy in stroke 
Apathy, in the acute and early subacute phase of stroke, may be the product of 
functional changes to nodes that are either part of or distant from the initial infarct. This is 
supported by a study of apathy and N-acetylaspartate (NAA) in first-time ischemic stroke 
patients (Glodzik-Sobanska et al., 2005). NAA is a nervous system-specific metabolite that may 
reflect myelin lipid turnover and mitochondrial energy production in humans, and can be 
interpreted as a marker for overall neuronal health (Moffett et al., 2007). Remarkably, the 
authors found that patients with apathy had reductions in prefrontal NAA levels despite all 
participants having lesions outside the frontal lobes, which was apparent an average of nine 
days post-stroke (Glodzik-Sobanska et al., 2005). In a similar vein, an electroencephalography 
study of patients with subcortical stroke showed that apathy was associated with decreased P3 
amplitude and reduced P3 latency over frontal sites (Yamagata et al., 2004). The P3 is an event-
related potential evoked by novel stimuli (Friedman et al., 2001), and the P3 changes 
documented by the authors may be consistent with decreased network efficiency in distant 
regions. 
Studies of apathy and rCBF show converging results. rCBF is a measure of the brain's 
hemodynamic response, which is spatially and temporally coupled to changes in local field 
potentials elicited by synaptic activity (Shibasaki, 2008). As a result of this neurovascular 











and Mintun, 2006). Apathy has been associated with reduced prefrontal rCBF in patients with 
subcortical stroke, as well as cerebellar and thalamic infarcts (Demirtas-Tatlidede et al., 2013; 
de Oliveira Lanna et al., 2012; Okada et al., 1997), suggesting functional changes in neural 
populations distant to the acute infarct. Moreover, apathetic patients showed lower rCBF in the 
basal ganglia compared to non-apathetic patients one month after stroke (Onoda et al., 2011). 
These functional changes may persist for several years, as demonstrated by a case study of a 
patient with severe apathy who showed aberrant functional connectivity, assessed using 
resting-state functional MRI, in ACC despite a lack of lesions in that area (Siegel et al., 2014). 
Functional connectivity deficits and apathy levels remained stable after three years (Siegel et 
al., 2014). These findings further support the notion that apathy may occur as a syndrome of 
functional diaschisis in patients with stroke. That said, more longitudinal research is required to 
examine whether functional changes really lead to apathy. 
Structural changes may later follow these functional changes. One study, which 
assessed ischemic stroke patients during the subacute phase of stroke (10-28 days) and six 
months after the event, found that increasing apathy was associated with delayed atrophy in 
the posterior cingulate cortex (Matsuoka et al., 2015). This atrophy may be the product of 
anterograde transneuronal degeneration (Fornito et al., 2015), which can occur between 18-54 
months post-stroke (Duering et al., 2015). This secondary neurodegeneration is studied 
primarily using diffusion tensor imaging (DTI), an MRI technique used to measure molecular 
diffusion in biological tissue. Due to the hindered nature of water diffusion in tissues with 
complex architecture, such as those with coherent myelin fiber orientations, DTI measures such 











white matter (Basser and Pierpaoli, 1996). DTI data can also be used for tractography, which 
attempts to reconstruct three-dimensional white matter pathways through a continuous 
diffusion vector field (e.g., Mori et al., 1999). 
Evidence to support transneuronal degeneration as a network mechanism underlying 
apathy comes from two case studies of post-stroke patients with apathy with left or right 
caudate lesions in addition to prefrontal damage (Jang et al., 2019; Jang and Kwon, 2018). Both 
studies used diffusion tractography to reconstruct white matter pathways emanating from the 
caudate nucleus of both hemispheres. In both cases, white matter tracts joining the caudate 
and prefrontal cortex could not be reconstructed from the lesioned caudate even in areas 
lacking a radiologically visible infarct. Furthermore, caudate-prefrontal connectivity profiles 
were also truncated in the non-lesioned caudate in the opposite hemisphere. This suggests that 
secondary neurodegeneration resulting in cortical disconnection was a factor underlying apathy 
in these patients. This is further evidenced by associations between apathy and lesions to the 
internal capsule (Starkstein et al., 1993; Tatemichi et al., 1992), as well as reduced FA in the 
genu of the corpus callosum, anterior corona radiata, and white matter of the inferior frontal 
gyrus (Yang, X.-y. Shang, et al., 2015). 
These white matter changes are likely to have direct consequences on whole-brain 
network connectivity. One study that explored tractography-derived white matter networks in 
ischemic stroke patients showed that apathy was associated with decreased degree in 24 nodes 
across the cerebral cortex (Yang, Hua, et al., 2015). This included changes to the bilateral 
inferior frontal gyrus pars orbitalis, bilateral posterior cingulum, left SMA, and right putamen 











parietal lobes, as well as the insula. These changes in nodal degree were paralleled by 
decreased global and local efficiency in the nodes of the apathy-related subnetwork. Notably, 
DTI data was acquired within seven days of stroke onset, while assessments of apathy were 
conducted one month post-stroke. We can therefore conclude that early changes in the 
connectivity between these regions may predict the onset of apathy one month later. Whether 
these network changes result in apathy contemporaneously remains unexplored. 
This is not to suggest that apathy, during the acute and post-acute phases of stroke, is 
only a product of diaschisis and transneuronal degeneration. Focal lesions to GDB-related hub 
nodes may lead to immediate network failure and apathy. For instance, apathy is a prominent 
feature of many patients with isolated ACC (Kumral et al., 2019), thalamic (Ghika-Schmid and 
Bogousslavsky, 2000), and striatal infarcts (Bhatia and Marsden, 1994). Similarly, reward 
sensitivity deficits, which are associated with apathy in chronic stroke patients, can be mapped 
to lesions in structures that include the ventral basal ganglia, thalamus, and PFC (Adam et al., 
2013; Rochat et al., 2013). These demonstrate that hub node lesions can affect networks at 
large, without spreading to connected nodes. 
These results suggest that post-stroke apathy can result from two different types of 
damage. One is driven by an acute lesion to a hub node, which causes immediate network 
failure and apathy. The other is driven by an acute lesion to a peripheral node, which, if 
connected to a hub node, can lead to a decrease in functioning of that hub node. Over time, 
these functional changes may lead to structural changes, such as cortical atrophy due to a loss 
of synaptic input. Our model therefore suggests that connectomal diaschisis, later followed by 











where the initial infarct occurs in a non-hub node. These connectivity changes could result in 
decreased global and local efficiency due to disconnection or disruption of the white matter 
networks underlying GDB. 
This view of the pathogenesis of post-stroke apathy allows us to explain two major 
inconsistencies in the current literature. One is the lack of association between apathy and 
lesion location. As previously discussed, lesion location alone cannot adequately capture distant 
structural or functional changes that may lead to apathy. This may be why pairwise 
comparisons of lesion location in stroke patients with apathy against those without apathy yield 
negative results, while studies examining all patients with apathy find common structural and 
functional changes (e.g., Okada et al., 1997; Yang et al., 2015). 
The second inconsistency concerns the trajectory of post-stroke apathy. Some patients 
without apathy in the acute phase develop it up to one year later, while some patients with 
apathy in the acute phase are apathy-free later (Caeiro, Ferro, Pinho e Melo, et al., 2013; 
Withall et al., 2011). Some of this may well be attributable to measurement error, as a 
diagnosis of apathy is usually made using cut scores on clinical scales. However, a potential 
neurobiological explanation for this crossover effect may be individual changes in functional 
network dynamics. In the former scenario, later-onset apathy may be the result of time-
dependent post-stroke transneuronal degeneration, as previously described. Indeed, overall 
levels of apathy tend to increase in stroke patients over five years, although this may be due to 
subsequent cerebrovascular incidents (Brodaty et al., 2013). 
In the latter case, remitting apathy may be the result of functional network 










recovery after stroke (Grefkes and Fink, 2014). This entails an initial disruption of functional 
network connectivity following stroke, which is then followed by a gradual restoration of 
interhemispheric functional connectivity over several months in individuals who recover 
function (van Meer et al., 2010). Evidence to support this functional network recovery in stroke 
patients with apathy comes from case studies using brain stimulation. Repetitive transcranial 
magnetic stimulation (rTMS) coils induce electrical fields that lead to the depolarization of 
superficial cortical axons, inducing activity in potentially disrupted networks (Lefaucheur et al., 
2014). This form of stimulation, applied in certain cortical areas, may lead to a recovery of 
function over many sessions. 
Such a recovery has been demonstrated in a sample of 13 chronic stroke patients who 
received high-frequency rTMS over the ACC and medial PFC, two putative hub nodes (Sasaki et 
al., 2017). After five days of treatment, individuals in the rTMS group showed an improvement 
in apathy symptoms. In contrast, apathy scores in individuals assigned to the sham condition 
remained static. That said, the five-day treatment regime used in this study is relatively short, 
and the final apathy assessment took place immediately after the final rTMS session. This 
makes it difficult to determine whether the improvements seen in this study reflect genuine 
functional network reorganization or transient network changes observed during or directly 
after high-frequency rTMS sessions (Sack, 2006). 
A case study suggests that these rTMS-based decreases in post-stroke apathy are 
associated with improved interhemispheric activity (Mitaki et al., 2016), suggesting a direct 
parallel with the mechanisms underlying motor recovery after stroke. This functional network 











damaged tissue (Dancause, 2006). It has been suggested that structures that show similar 
connectivity profiles to the damaged tissues may be more likely to adopt these functions (Silasi 
and Murphy, 2014). Thus, an accurate understanding of the structural network basis of GDB 
may open up new targets for rTMS-based recovery in patients with post-stroke apathy. 
3.4. Apathy in cerebral small vessel disease 
Cerebral SVD is a term used to describe the pathologies that affect the small vessels of 
the brain, which include the small arteries, arterioles, and venules (Pantoni, 2010). SVD is the 
leading vascular cause of dementia (Pantoni, 2010). Most SVD is sporadic and related to age 
and vascular risk factors such as hypertension, but a minority of cases are caused by monogenic 
disorders, such as Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and 
Leukoencephalopathy (CADASIL) (Pantoni, 2010). SVD-related pathology is heterogenous and 
can manifest radiologically as lacunes, WMH, or microbleeds, among others (Wardlaw et al., 
2013). These may occur in tandem with microstructural degeneration in major white matter 
tracts, leading to cognitive deficits that some have suggested to be the result of a disconnection 
syndrome (Lawrence et al., 2013; O’Sullivan et al., 2005). 
Mounting evidence suggests that white matter damage may underlie apathy in SVD. 
Apathy has been associated with reduced FA in major white matter tracts such as the anterior 
cingulum and corpus callosum in patients with sporadic SVD (Hollocks et al., 2015) (Figure 2A). 
FA reductions in these same tracts were found to be associated with apathy in CADASIL (Le 
Heron, Manohar, et al., 2018) (Figure 2B), an early-onset model of SVD free of age-related 











found to be associated with disruption to large-scale white matter networks in SVD (Tay et al., 
2019) (Figure 2C). 
FIGURE 2 AROUND HERE 
Widespread white matter network damage is a known consequence of SVD (Tuladhar et 
al., 2019), although the etiology of this phenomenon remains incompletely understood. 
Research in this area largely focuses on understanding the pathophysiology underlying the 
radiological manifestations of SVD (Wardlaw et al., 2019). Apathy in particular has been 
associated with lacunar infarcts and WMH (Grool et al., 2014; Lavretsky et al., 2008; Sarabia-
Cobo et al., 2014; Starkstein et al., 1997; Tay et al., 2019; Yao et al., 2009). We will now review 
the cerebrovascular pathologies that putatively underpin these markers of SVD and how they 
may lead to network damage. 
Lacunar infarcts, while an important marker of SVD, have indirectly been covered in 
Section 3.3, as these tend to be sources of subcortical infarcts (Wardlaw et al., 2013). Although 
lacunes have different etiologies than large artery infarcts, which arise from the occlusion of 
larger cerebral arteries and often involve the cortex, both types of stroke tend to result in 
similar pathophysiological cascades, and thus similar patterns of network damage (Duering et 
al., 2015). The relationship between apathy and other radiological markers of SVD such as 
microbleeds, cortical microinfarcts, and enlarged perivascular spaces has yet to be explored. 
WMH appear as areas of high signal intensity on T2-weighted MRI, and may reflect 
areas of ischemic demyelination and axonal loss resulting from chronic hypoperfusion (Fazekas 
et al., 1993; Fernando et al., 2006). These lead to changes in the underlying white matter 











NAA in proximal normal-appearing white matter (Firbank et al., 2003; van Leijsen, Bergkamp, et 
al., 2018). Tract-specific WMH progression is also related to incident cortical atrophy in the 
regions connected by that tract (Lambert et al., 2016). This suggests that WMH-related network 
damage can be characterized by transneuronal degeneration, which originates in hypoperfused 
white matter and progresses down tracts. This then leads to atrophy in connected regions due 
to the progressive disruption of synaptic inputs. 
WMH have been correlated with higher apathy levels in population-based cohort 
studies (Grool et al., 2014; Yao et al., 2009), and Alzheimer's disease patients with WMH have 
higher levels of apathy compared to patients without WMH (Starkstein et al., 1997). These are 
paralleled by lower rCBF in basal ganglia, thalamus, and frontal lobes (Starkstein et al., 1997), 
suggesting that WMH lead to functional disruption of GDB-related hub nodes, which may 
impact network efficiency. This notion is supported by a study of SVD patients that showed that 
global white matter network efficiency fully mediated the relationship between WMH volumes 
and apathy (Tay et al., 2019). Although these results are cross-sectional, they suggest that 
WMH are related to apathy through the disruption of network efficiency. This, coupled with 
progressive neurodegeneration and consequent cortical thinning, may be a factor underlying 
apathy in SVD. The consequences of this chronic ischemia, together with the earlier mentioned 
effect of acute infarcts, suggests a potential cascade linking ischemia to apathy (Figure 3). 










4. Neurocognitive mechanisms underlying apathy 
If damage to distinct networks leads to the behavioral symptoms of apathy, then they 
may do so through defined neurocognitive mechanisms. For the purposes of this review, we will 
consider apathy to be a deficit in the cognitive processes underlying effort-based decision 
making due to the conceptual simplicity and operationalizability of this approach (Le Heron, 
Apps, et al., 2018; Le Heron et al., 2019). This view suggests that behavior can be thought of in 
three distinct phases: 
1. Deciding whether to pursue a behavior; 
2. Performing and persisting with the behavior; and 
3. Evaluating and learning the costs and benefits of a behavior. 
4.1. Reward-based decision-making 
Prior to any behavior occurring, an individual must decide whether or not that behavior 
is worth engaging in. This engages networks that underlie cost-benefit valuation, as rewards 
and effort costs must be appraised. Apathy may therefore be the result of reductions in reward 
sensitivity, which is typically operationalized as an tendency to respond in proportion to the 
value of a rewarding stimulus during a behavioral task. 
Recent evidence suggests that reduced incentivization to rewards may be a mechanism 
underlying apathy in cerebrovascular disease. Decreased reward-related task speeding is 
associated with apathy in chronic stroke patients (Rochat et al., 2013). Similarly, CADASIL 
patients with apathy rejected more opportunities to exert effort during a task, and were slower 











Manohar, et al., 2018). This was paralleled by reduced FA in the anterior cingulum, white 
matter of the OFC, and the anterior internal capsule (Le Heron, Apps, et al., 2018). Rejection of 
opportunities to exert effort suggests that apathy in these patients reflects a devaluation of 
rewards, while the increased decision-making time and concurrent white matter damage may 
reflect disrupted network efficiency. This is directly supported by a study of white matter 
subnetworks in sporadic SVD patients, which showed that the global efficiency of a reward-
related subnetwork was more correlated with apathy than motor or visual subnetworks 
(Lisiecka-Ford et al., 2018). The reward-related subnetwork included nodes such as ACC, OFC, 
and putamen (including ventral striatum), among others (Lisiecka-Ford et al., 2018). Changes in 
the connectivity between these frontostriatal structures was associated with apathy in an 
independent cohort of sporadic SVD patients (Tay et al., 2019). 
This collective evidence suggests a direct pathway between cerebrovascular pathology, 
network change, cognitive deficits, and apathy. First, neuropathological changes lead to 
frontostriatal network damage, either through cortical or subcortical infarcts that lead to 
secondary neurodegenerative cascades down white matter tracts (Duering et al., 2015; 
Schaapsmeerders et al., 2016), or through frontal WMH, which represent areas of ischemic 
demyelination and axonal loss (Gouw et al., 2011). Both infarcts and WMH may also lead to 
incident cortical atrophy in connected regions (Duering et al., 2015; Lambert et al., 2016). The 
progressive destruction or disruption of these frontal white matter tracts may lead to a 
decrease in the efficiency of information transfer along these tracts, making the integration of 
reward-related signals between structures such as ACC, ventral striatum, and PFC (Haber and 











value of a stimulus, manifesting as a reduction in GDB and apathy. These deficits in reward 
sensitivity may well be synonymous with the 'affective blunting' described in accounts of 
apathy related to impaired emotional processing (Levy and Dubois, 2006). 
These changes may be modulated by dopaminergic neurons, which originate in the 
ventral tegmental area and substantia nigra and project to the ventral striatum, ACC, 
ventromedial PFC, and OFC (Chong and Husain, 2016). Dopamine may promote approach 
behaviors by attributing incentive salience to rewarding stimuli (Chong and Husain, 2016). 
Accordingly, case studies show that the administration of dopamine agonists can alleviate 
apathy in some stroke patients. These include bromocriptine (Barrett, 1991; Catsman-
Berrevoets and Harskamp, 1988; Marin et al., 1995; Parks et al., 1992; Powell et al., 1996), and 
ropinirole (Adam et al., 2013; Kohno et al., 2010). 
Changes in dopaminergic neurotransmission may explain associations between apathy 
and inflammation (Chen et al., 2018; Eurelings et al., 2015). Systemic inflammation can be 
estimated by circulating plasma C-reactive protein (CRP) levels, which are elevated following an 
inflammatory response (Pepys and Baltz, 1983). Elevated acute phase CRP levels are associated 
with increasing post-stroke apathy over six months (Chen et al., 2018). Similarly, apathy was 
correlated with higher CRP levels over several years in community-dwelling individuals 
(Eurelings et al., 2015). This relationship may be driven by inflammation-associated decreases in 
dopamine synthesis and availability, reducing neural responses toward rewarding stimuli 
(Felger and Treadway, 2017). It should be noted, however, that inflammation itself is related to 
incident vascular disease (Gounis et al., 2015), meaning that the relationship between 











(Yao et al., 2019). Clearly dissociating the direct and indirect effects of inflammation on apathy 
is an important topic for future research. 
4.2. Attentional control during behavior 
After a behavior is initiated, it must be sustained until completion to achieve the desired 
outcome. This involves not only monitoring current outcomes of a task, but also comparing the 
potential value of completing the current task to others which are potentially more rewarding. 
If this is the case, then it possible that patients with apathy may also show deficits in cognitive 
flexibility. 
There is some indirect evidence to support this hypothesis. Apathy is associated with 
worse performance on composite cognitive indices that include the Trail Making Test Part B 
(TMT-B) (Reitan, 1958) in stroke and SVD (Douven et al., 2018; Lohner et al., 2017). TMT-B 
performance requires individuals to draw a line between alternating numbers and letters in 
consecutive order, and completion requires the maintenance of a long sequence of behaviors 
as well as the ability to switch between two contexts (numbers and letters) (Kortte et al., 2002). 
The reduction in TMT-B performance may reflect patient difficulties in completing a long 
sequence of behaviors, switching between rewarding contexts, or switching to more rewarding 
options. The latter two, while difficult to dissociate using current data on the TMT-B, may 
reflect difficulties in sustaining motivation through a task. 
These associations, however, are indirect, as TMT-B performance in both studies was 
included in a larger composite index that included other measures of executive functioning 











robust and easy to interpret, variance in the measures used to construct them may obfuscate 
true associations. For instance, another study that measured executive function using the TMT-
B found no correlation between executive function and apathy scores (Brodaty et al., 2005). 
This may be due to that executive function index including a color-form sorting task, which may 
assess different cognitive abilities than TMT-B (Tamkin and Kunce, 1982). The inclusion of both, 
therefore, may have dampened associations with apathy. More direct testing of these 
constructs, as well as careful consideration towards tests used to create composite cognitive 
indices, is required before any definitive conclusions can be drawn. 
The deficits discussed above may be associated with impairment of the fronto-parietal 
and cingulo-opercular networks, two intrinsic connectivity networks derived from resting-state 
functional MRI data (Seeley et al., 2007). The fronto-parietal network includes the dorsolateral 
PFC, inferior parietal lobule, intraparietal sulcus, precuneus, and middle cingulate, while the 
cingulo-opercular network includes anterior PFC, anterior insula, dorsal ACC, and thalamus 
(Seeley et al., 2007). Both networks have been implicated in attentional control processes, with 
fronto-parietal network initiating and adjusting behavior on a task-to-task basis, while the 
cingulo-opercular network provides stable maintenance of task goals over the entire behavioral 
period (Dosenbach et al., 2008). 
Apathy in SVD patients is associated with altered connectivity in white matter networks 
that have a similar topological organization to these intrinsic connectivity networks (Tay et al., 
2019). Furthermore, after controlling for general cognitive functioning, which included 
measures of attention, apathy was no longer associated with these particular white matter 











was conducted, structural connectivity has been shown to constrain functional connectivity in 
the human brain (Honey et al., 2009). Therefore, structural damage to the nodes or edges 
supporting the fronto-parietal and cingulo-opercular networks may result in attentional deficits. 
These make the maintenance of task-related GDB more difficult, manifesting as apathy. It 
should be noted that all current evidence that supports this notion is indirect, highlighting the 
need for more focused, theory-driven network analyses of apathy. 
4.3. Learning and remembering rewarding behaviors 
After a behavior has been completed, outcomes reveal whether the behavior was a 
success or failure. The magnitude of the success or failure, in relation to the effort exerted to 
complete the task, informs individuals of how worthwhile the task was. Deficits in learning this 
action-outcome contingency may impair individuals from learning rewarding behaviors, which 
may manifest as apathy (Husain and Roiser, 2018). 
Evidence, in general, supports an association between apathy and impaired measures of 
verbal recall and recognition in stroke and SVD (Brodaty et al., 2005; Fishman et al., 2018a; 
Lohner et al., 2017), although some studies do not find this association (Douven et al., 2018). In 
accordance with this, apathy has been found to be associated with reduced FA in the fornix, the 
major output tract of the hippocampus, in sporadic SVD (Hollocks et al., 2015), as well as with 
reduced nodal degree in left hippocampus in ischemic stroke patients (Yang, Hua, et al., 2015). 
That said, apathy has not been found to be associated with hippocampal connectivity in a less 
severe cohort of SVD patients (Tay et al., 2019), and apathy is not associated with reduced 











Yang, X.-y. Shang, et al., 2015). Apathy is also not generally associated with altered medial 
temporal lobe connectivity in stroke or SVD, despite lateral temporal lobe differences being 
found (Tay et al., 2019; Yang, Hua, et al., 2015). 
Apathy has also been documented as a comorbidity with amnesia following thalamic 
stroke (Carrera and Bogousslavsky, 2006; Catsman-Berrevoets and Harskamp, 1988; Guberman 
and Stuss, 1983). This may be due to the reciprocal connections between the thalamus and the 
hippocampus via the mammillo-thalamic tract, which includes the fornix (Carlesimo et al., 
2011). Interpreting this is not straightforward, however, as disrupted white matter connectivity 
between the thalamus and PFC may also underlie apathy (Tay et al., 2019). Future research 
could clarify whether thalamic-hippocampal connectivity plays a role in learning and memory 
deficits associated with apathy by examining tract-specific white matter microstructure in 
patients with vascular thalamic amnesia and apathy. 
The evidence to support a link between cerebrovascular disease, medial temporal 
network damage, learning and memory deficits, and apathy therefore remains inconclusive. 
These associations may be further complicated by depression and Alzheimer's disease 
pathology in elderly patients, both of which are associated with medial temporal lobe changes 
that may interact with cerebrovascular pathology to produce age-related changes in learning 
and memory (Geerlings et al., 2008; van Leijsen, Tay, et al., 2018). More focused behavioral 
experiments, together with more rigorous sample population phenotyping, may be able to 
better clarify these relationships. 
Aside from the medial temporal lobes, damage to structures such as the ACC and VS 











conditioning (Parkinson et al., 2000). Dopaminergic neurons within VS provide a key substrate 
for reward prediction error signals (Pagnoni et al., 2002), which in turn are used by ACC to 
update internal models of the environment and task (Kolling et al., 2016). Damage to these 
structures may therefore lead to learning deficits which lead to improper value signaling, 
thereby leading to inaccurate reward-based decisions (e.g. Section 4.1). 
Links between these components of GDB, underlying cognitive functions, and potential 
subnetworks that may support these are shown in Figure 4. It is important to note that the way 
we have presented these is, overall, a simplified view of how neurobiological networks might 
be related to apathetic behaviors. It is unlikely that one single subnetwork or connection 
underlies a specific behavior or cognition, as this is quite contrary to the notion of networks in 
general. For instance, attention must be sustained throughout all phases of behavior, as a lack 
of attention may impair decision-making and learning. Instead, we have highlighted specific 
cognitive functions that may be particularly important to a certain phase of behavior, and have 
related that to properties of established functional networks that may be disrupted in 
cerebrovascular disease. Interactions between these networks, which could be mediated by 
GDB-related hub nodes, may well play a role in determining multiple components of behavior. 
FIGURE 4 AROUND HERE 
5. Apathy as a predisposing factor for vascular disease 
The relationship between apathy and cerebrovascular disease raises an interesting 
question regarding causality. On one hand, apathy could be the result of cerebrovascular 











are important for mitigating vascular risk factors, which could then cause cerebrovascular 
disease. Although the latter scenario is not related to mechanisms linking cerebrovascular 
disease to apathy per se, reverse causality is an important methodological consideration for 
future studies investigating apathy, and therefore merits some discussion. As a result, we will 
briefly discuss evidence that shows that apathy can be a predisposing factor for incident 
vascular disease, as well as the relationships between apathy and specific vascular risk factors. 
Large, community-based cohort studies have found that apathy is associated with 
higher rates of cardiovascular diseases other than stroke, such as myocardial infarction, angina 
pectoris, or peripheral artery disease (Ligthart et al., 2012; Van der Mast et al., 2008). 
Furthermore, apathy is an independent risk factor for incident cardiovascular disease after two-
year follow-up, even after adjustment for demographic factors, cardiovascular risk factors, 
cognition, and disability (Eurelings et al., 2014). This implies that apathy is associated with 
increased vascular burden, which is borne out by data from a large cohort study showing that 
apathy is associated with increased vascular risk factors such as elevated systolic blood 
pressure, high body mass index (BMI), and type 2 diabetes mellitus (Ligthart et al., 2012). A 
follow-up study in the same cohort suggested that the relationships between apathy and 
incident vascular disease was primarily mediated by physical inactivity, along with diabetes and 
smoking (Eurelings et al., 2016). Associations between apathy and physical inactivity have been 
reported in other populations (Yao et al., 2015). 
Apathy may also lead to vascular disease through diabetes mellitus. In a large sample of 
community-dwelling individuals, diabetes was shown to partially mediate the relationship 











with diabetes have higher apathy compared to healthy controls (Bruce et al., 2015). This raises 
the possibility that apathy may be a contributory factor leading to diabetes, which in turn leads 
to vascular disease. This relationship may be attributed to apathy causing diabetic patients to 
be less adherent to exercise plans or insulin regimes, which is reflected in slightly elevated 
levels of glycated hemoglobin (HbA1c) in apathetic diabetes patients compared to diabetics 
without apathy (Padala et al., 2008). 
These lines of evidence imply that apathy may play a role in incident vascular disease. 
Subthreshold levels of apathy in healthy individuals are associated with individual differences in 
structural and functional connectivity in ACC and SMA (Bonnelle et al., 2015), important areas 
underlying apathy (see Sections 3.2 and 4). 
Given this evidence, it is tempting to speculate that a higher body mass index (BMI) 
should be one of the manifestations of apathy, given its association with exercise. However, 
apathy has been associated with lower BMI and weight loss in patients with pre-existing 
neurological diseases (Rodríguez-Violante et al., 2014; Sobów et al., 2014; Volicer et al., 2013). 
Apathy in outpatients with Alzheimer's disease has actually been associated with nutritive 
deficits (Benoit et al., 2008), suggesting that apathetic patients may be less inclined to eat. This 
may lead to a deficiency in dietary vitamins such as vitamin B6, B12, and folate, which can lead 
to elevated homocysteine levels and subsequent strokes (He et al., 2004; Larsson et al., 2019). 
It is therefore possible that apathy may lead to incident vascular disease through two 
pathways. One is through individual differences in network structural and functional 
connectivity in GDB-related regions, leading to individuals who do not adequately manage their 











pre-existing diseases, such as Alzheimer's, where patients may not engage in important 
behaviors related to self-maintenance, such as eating. The reciprocal relationships between 
apathy and vascular disease can be found in Figure 5. 
FIGURE 5 AROUND HERE 
6. Model predictions and future directions 
The network-based view of apathy that we have proposed, along with the potential 
cognitive mechanisms that may link network damage to apathy, provide a fruitful basis for 
future hypotheses. Our model can be tested on multiple levels, including: the specific 
cerebrovascular pathologies that lead to network damage in stroke and SVD (Section 3), the 
neurocognitive processes proposed to support motivated behavior, and the anatomical and 
functional specificity of the subnetworks that may support these processes (Section 4). Some 
testable and falsifiable questions that arise from a network-based model of apathy are 
highlighted in Box 1. 
BOX 1 AROUND HERE 
Validation of the specific hub nodes and subnetworks underlying apathy in stroke and 
SVD (Tay et al., 2019; Yang, Hua, et al., 2015) may lead to a better understanding of the 
structural and functional connections and subnetworks that are impaired in individuals with 
specific cerebrovascular pathologies. These pathologies may include the under-explored areas 
of post-stroke neuroinflammation or the ischemic penumbra, which may play roles in 
exacerbating or alleviating apathy. Moreover, a clearer understanding of specific subnetwork 











Lisiecka-Ford et al., 2018). These subnetworks could also be examined in the context of other 
comorbidities, such as depression and fatigue (Douven, Köhler, Schievink, et al., 2017), in order 
to identify common underlying mechanisms. 
Studies on the trajectories of post-stroke apathy could investigate whether functional 
diaschisis underlies apathy in the acute phase. Longitudinal research could examine whether 
patients who recovery from apathy show corresponding improvements in intrahemispheric 
connectivity or vicariation, and if individuals who develop apathy show transneuronal 
degeneration in connected cortical regions. These network pathologies should help explain why 
apathy develops after lesions in certain areas. 
Further inquiry into the validity of the presented neurocognitive framework for apathy 
is needed, as well as the subnetworks that support these cognitive functions. This could involve 
behavioral paradigms or cognitive tests that assess specific constructs that may be related to 
apathy, with additional consideration to any comorbidities that a patient might show. Doing so 
may identify which components of GDB are disrupted in patients with cerebrovascular disease. 
Additionally, work on how some cognitive mechanisms may be related to multiple phases of 
GDB is needed, as this evidence is largely absent. 
It is possible that many of these questions could also be evaluated in animal models. 
Although apathy per se is not traditionally investigated in animal studies, several components of 
GDB, such as option generation, action initiation, and learning have been investigated in rodent 
models (see Husain and Roiser, 2018). This work could be extended by new studies that use 
experimental stroke models such as photothrombosis and endothelin-1 to model circumscribed 











regions to determine whether disruption to the proposed hub nodes and subnetworks leads to 
the distinct neurocognitive deficits that may underlie apathy (Section 3.2 and 4). 
All of these lines of research could lead to targeted interventions for treating apathy. 
For instance, an apathetic patient with damage in a defined apathy-related subnetwork might 
be treated with rTMS, which requires a priori knowledge of which nodes may be disrupted. 
Such rTMS approaches have some preliminary support (Mitaki et al., 2016; Sasaki et al., 2017). 
Alternatively, subnetwork-specific neurotransmitter deficits could be addressed with 
pharmacological agents, such as dopamine agonists, which lead to a reinstatement of the 
related component of GDB (Adam et al., 2013). Treating apathy may not only lead to 
improvements in patient functional outcomes, but also lower the risk of future vascular disease. 
Cerebrovascular pathology also plays an important part in neurodegenerative conditions 
such as Alzheimer's disease (Korczyn, 2002), which could potentially lead to more severe 
apathy. For instance, Alzheimer's disease patients with WMH have higher levels of apathy 
compared to Alzheimer's patients without WMH (Starkstein et al., 1997). Given these findings, 
it is possible that understanding apathy in cerebrovascular disease could lead to potential 
mechanistic insights and treatment approaches into apathy in other neurological conditions. 
These findings also suggest that our network-based model of apathy may be extensible 
and generalizable to other conditions. For instance, different neurodegenerative diseases target 
distinct large-scale networks (Seeley et al., 2009), making it reasonable to assume that disease-
specific patterns of network damage could lead to different symptoms of apathy. Modeling 











motivational impairments in specific diseases, which could assist in clinical phenotyping. 
Findings could then be integrated across diseases to identify core networks underlying GDB. 
Finally, future research should also focus on verifying the proposed pathways linking 
apathy to incident vascular disease (Section 5). The preliminary evidence we have presented 
suggests that apathy in otherwise neurologically healthy individuals may lead to incident 
vascular disease, although further replication with more detailed measures of apathy is 
required. If these relationships are verified, then addressing subthreshold levels of apathy in 
the general population may lead to an overall reduction in vascular burden, which has 
important implications for public health (Baumgart et al., 2015). 
7. Conclusion 
Apathy is a complex phenomenon that cannot be fully explained by current lesion-based 
theories. To address this, we have proposed a network-based model of apathy that connects 
cerebrovascular disease - both focal lesions, such as ischemic and hemorrhagic stroke, and 
widespread white matter disruption, such as in SVD - to observed neurobiological changes. The 
evidence reviewed suggests that network pathologies, particularly diaschisis and transneuronal 
degeneration, can be used to explain how apathy may present in individuals without direct 
GDB-related hub node damage. These pathologies may also be able to explain improving or 
worsening trajectories of apathy over time. Our consideration of the literature suggests 












Conceptualizing of apathy as the result of large-scale network pathologies may open 
new pathways for investigating its neurobiology, clinical presentation, and longitudinal 
trajectory. Validation of the cognitive components of apathy, as well as the specific 
subnetworks that support these, may help in understanding the specific GDB-related networks 
that are affected in patients with cerebrovascular disease. This has the potential to lead to 
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 A network-based framework of apathy leads to several potential lines of inquiry. These can be 
broadly categorized into three inter-related domains, namely, the cerebrovascular pathologies 
that lead to apathy-related network damage, the neurocognitive mechanisms that may 
underlie apathy, and the specific subnetworks supporting these neurocognitive functions. 
These yield testable and falsifiable questions, such as: 
1. Cerebrovascular pathologies 
– Do circumscribed strokes in hub nodes lead to acute apathy? 
– Do strokes in peripheral nodes lead to increasing apathy over time? 
– Is increasing apathy associated with connectomal diaschisis or transneuronal 
degeneration? 
– Can these network pathologies be mapped to stereotyped pathophysiological 
cascades after stroke, such as anterograde (Wallerian) degeneration? 
2. Neurocognitive mechanisms 
– Can different presentations of apathy be associated with deficits in the 
neurocognitive domains described? 
– Do apathetic patients show difficulties in making rewarding decisions? 
– Do apathetic patients show difficulties in switching between rewarding contexts? 
– Do apathetic patients show difficulties in learning rewarding behaviors? 
3. Subnetwork functioning 
– Do specific subnetworks correspond to the abovementioned neurocognitive 
processes (e.g., does damage to the ACC-insula-orbitofrontal-VS subnetwork lead 
to reward sensitivity deficits?) 
– Do previously identified structural subnetworks (e.g., Tay et al., 2019; Yang et al., 
2015) include all relevant nodes and connections? 
– Can the function of specific subnetworks be mapped to discernable neural 
processes (e.g., is learning subnetwork function associated with aberrant reward 
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Figure 1. Basic network measures and pathology. a, The degree of a node is a measure of how 
many connections it has. b, The shortest path between two nodes is a measure of efficiency. c, 
Diaschisis is a functional deficit in a region that is remote from a damaged node; d, 
Transneuronal degeneration involves the physical breakdown of nodes, which propagates from 













Figure 2. White matter network damage associated with apathy in cerebral small vessel disease 
(SVD). a, Apathy is associated with reduced white matter fractional anisotropy (FA) in patients 
with sporadic SVD. Red = FA voxels associated with apathy. b, CADASIL patients with apathy 
show reduced FA compared to CADASIL patients without apathy. Red = areas of reduced FA in 
apathetic CADASIL patients, green = white matter skeleton. c, Reductions in white matter 
network connectivity associated with apathy in sporadic SVD. Apathy is associated with a 
distributed pattern of white matter damage across the cortex, implicating several subnetworks 
in the pathogenesis of apathy. White matter damage related to apathy is consistent in sporadic 
and genetic SVD, suggesting a common basis. Adapted from Hollocks et al. (2015), Le Heron, 
Manohar, et al. (2018), and Tay et al. (2019) with permission. AC = anterior cingulum; PC = 
posterior cingulum; CC = corpus callosum; CCb = body of the corpus callosum; ATR = anterior 
thalamic radiation; IFOF = inferior fronto-occipital fasciculus; UF = uncinate fasciculus; SCP = 














Figure 3. Hypothesized mechanisms linking ischemic pathology to apathy. Chronic and acute 
ischemia may lead to different types of tissue damage. Specific types of lesions that lead to 
damage in strategic grey matter structures or white matter tracts, such as those related to hub 
nodes, may immediately lead to apathy. Over time, secondary neurodegeneration propagates 
from lesioned tissue to connected areas, leading to network disconnection and apathy. GM = 













Figure 4. Potential relationships between subnetworks, cognition, and components of goal-
directed behavior. Behavior may be thought of in three temporal phases: before, during, and 
after. Prior to behavior occurring, individuals must evaluate whether a behavior is worth 
engaging in. After a decision has been made, the behavior must be initiated and sustained. 
Once the behavior has been completed, the outcome of the behavior influences future 
decision-making. These may be supported by specific subnetworks implicated in incentive 
salience, executive control, and learning and memory. Some nodes may be part of multiple 
subnetworks, such as the anterior cingulate cortex (ACC) and ventral striatum (VS), as these 
may be hub nodes for goal-directed behavior. For simplicity, only one subnetwork has been 
listed per phase of behavior, though it should be noted that multiple subnetworks with more 













Figure 5. Pathways linking apathy to vascular disease. Individual differences in network 
functioning may lead to lower motivation in some individuals, This may lead to elevated risk 
factors such as physical inactivity, which may cause incident cardio- and cerebrovascular 
disease. Cerebrovascular pathology can exacerbate network damage and apathy, which has 
further consequences for managing vascular risk factors. J
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